News

January 10, 2020January 10, 2020

Approved Neurotrophic Keratitis Therapy Oxervate Requires Further Clinical Testing, According to Review

News

Despite its U.S. Food and Drug Administration approval, the safety and efficacy of Oxervate (cenegermin) as a treatment for the degenerative eye disease neurotrophic keratitis needs additional clinical testing, according ... Read more

January 3, 2020January 3, 2020

First Participant Enrolled in Phase 4 Clinical Trial Testing Acthar Gel for Severe Keratitis

News

The first participant has been enrolled in a Phase 4 clinical trial testing Acthar Gel — a repository corticotropin injection — in people with severe keratitis, according to Mallinckrodt Pharmaceuticals, ... Read more

December 20, 2019December 20, 2019

Bevacizumab Safe, Effective in Reducing Corneal Neovascularization, a Symptom of NK

News

Bevacizumab injection into the eye is safe and effective in reducing the abnormal formation of blood vessels in the cornea, a study suggests. This condition, called corneal neovascularization, is a symptom ... Read more

December 13, 2019December 13, 2019

Neurotrophic Keratitis More Common Than Reported, Study Finds

News

By reviewing several years worth of patient records, researchers have found that neurotrophic keratitis (NK) may be more common that previously reported. Early diagnosis and treatment also led to better ... Read more

December 6, 2019December 6, 2019

HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases

News

Despite skyrocketing healthcare costs, President Trump is committed to protecting the 30 million or so Americans with rare diseases and ensuring timely, affordable access to lifesaving treatments, the nation’s highest-ranking ... Read more

November 22, 2019November 22, 2019

Current and Potential Treatments for Corneal Ulcers Due to NK Show Promise, Study Says

News

Oxervate (cenegermin) and Cacicol (RGTA) are currently the primary treatments for persistent and difficult-to-treat corneal ulcers caused by neurotrophic keratitis (NK), a review study reports. Oxervate is approved in both the ... Read more

November 15, 2019November 16, 2019

Rare Disease Film Festival Highlights Patient and Researcher Unity

News

Rare disease-themed videos glowed on a large screen before an audience of people in wheelchairs, with crutches, and bearing oxygen tanks this Nov. 9 and 10 in San Francisco. Disorder: ... Read more

November 1, 2019November 1, 2019

Rare Case of Neurotrophic Keratitis and Herpes Virus Reactivation After Pain-relief Procedure Reported

News

A 57-year-old woman developed neurotrophic keratitis with a reactivated herpes zoster virus after she was given alcohol injections to relieve pain due to a cyst on the right side of ... Read more

October 25, 2019October 25, 2019

Neurotrophic Keratitis Can Be Side Effect of MP-TCP Surgery for Glaucoma, Case Reports Suggest

News

In people with poorer sensation in the cornea, neurotrophic keratitis (NK) can develop after undergoing micropulse transscleral cyclophotocoagulation (MP-TCP) to treat glaucoma, two case reports suggest. Risk factors for diminished ... Read more